A
Aldeyra Therapeutics D
D
ALDX
2.21500
USD
-0.04
(-1.56%)
مغلق
حجم التداول
20,026
الربح لكل سهم
-1
العائد الربحي
-
P/E
-2
حجم السوق
132,668,727
الأخبار المقالات
العنوان: Aldeyra Therapeutics
القطاع: Healthcare
الصناعة: Biotechnology
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.